Literature DB >> 8306688

High-dose epinephrine results in greater early mortality after resuscitation from prolonged cardiac arrest in pigs: a prospective, randomized study.

R A Berg1, C W Otto, K B Kern, A B Sanders, R W Hilwig, K K Hansen, G A Ewy.   

Abstract

OBJECTIVE: To determine whether high-dose epinephrine (0.2 mg/kg) during cardiopulmonary resuscitation (CPR) results in improved outcome, compared with standard-dose epinephrine (0.02 mg/kg).
DESIGN: A prospective, randomized, blinded study.
SETTING: Research laboratory of a university medical center. SUBJECTS AND
INTERVENTIONS: Thirty domestic swine were randomized to receive standard- or high-dose epinephrine during CPR after 15 mins of fibrillatory cardiac arrest. Three minutes of CPR were provided, followed by advanced cardiac life support per American Heart Association guidelines. Animals that were successfully resuscitated were supported for 2 hrs in an intensive care unit (ICU) setting, and then observed for 24 hrs.
MEASUREMENTS AND MAIN RESULTS: Electrocardiogram, aortic blood pressure, right atrial blood pressure, and end-tidal CO2 were monitored continuously until the intensive care period ended. Survival and neurologic outcome were determined. Return of spontaneous circulation was attained in 14 of 15 animals in each group. Four of 14 high-dose epinephrine pigs died during the ICU period after return of spontaneous circulation vs. zero of the 14 standard-dose pigs (p < .05). Six standard-dose pigs survived 24 hrs vs. four high-dose pigs. Twenty-four-hour survival rate and neurologic outcome were not significantly different. Within 10 mins of defibrillation, severe hypertension (diastolic pressure > 120 mmHg) occurred in 12 of 14 high-dose pigs vs. two of 14 standard-dose pigs (p < .01). Severe tachycardia (heart rate > 250 beats/min) occurred in seven of 14 high-dose pigs vs. zero of 14 standard-dose pigs (p < .01). All four high-dose epinephrine pigs that died during the ICU period experienced both severe hypertension and tachycardia immediately postresuscitation.
CONCLUSIONS: High-dose epinephrine did not improve 24-hr survival rate or neurologic outcome. Immediately after return of spontaneous circulation, most animals in the high-dose epinephrine group exhibited a hyperadrenergic state that included severe hypertension and tachycardia. High-dose epinephrine resulted in a greater early mortality rate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306688     DOI: 10.1097/00003246-199402000-00020

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  Experimental cardiac arrest treatment with adrenaline, vasopressin, or placebo.

Authors:  Manoel Ângelo Gomes Palácio; Edison Ferreira de Paiva; Luciano Cesar Pontes de Azevedo; Ari Timerman
Journal:  Arq Bras Cardiol       Date:  2013-11-01       Impact factor: 2.000

2.  A hemodynamic-directed approach to pediatric cardiopulmonary resuscitation (HD-CPR) improves survival.

Authors:  Ryan W Morgan; Todd J Kilbaugh; Wesley Shoap; George Bratinov; Yuxi Lin; Ting-Chang Hsieh; Vinay M Nadkarni; Robert A Berg; Robert M Sutton
Journal:  Resuscitation       Date:  2016-12-05       Impact factor: 5.262

Review 3.  Current Challenges in Neonatal Resuscitation: What is the Role of Adrenaline?

Authors:  Roberto Antonucci; Luca Antonucci; Cristian Locci; Annalisa Porcella; Laura Cuzzolin
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

4.  Sodium nitroprusside enhanced cardiopulmonary resuscitation improves survival with good neurological function in a porcine model of prolonged cardiac arrest.

Authors:  Demetris Yannopoulos; Timothy Matsuura; Jason Schultz; Kyle Rudser; Henry R Halperin; Keith G Lurie
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

5.  Hemodynamic directed cardiopulmonary resuscitation improves short-term survival from ventricular fibrillation cardiac arrest.

Authors:  Stuart H Friess; Robert M Sutton; Utpal Bhalala; Matthew R Maltese; Maryam Y Naim; George Bratinov; Theodore R Weiland; Mia Garuccio; Vinay M Nadkarni; Lance B Becker; Robert A Berg
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

6.  Postresuscitation myocardial dysfunction: correlated factors and prognostic implications.

Authors:  Wei-Tien Chang; Matthew Huei-Ming Ma; Kuo-Liong Chien; Chien-Hua Huang; Min-Shan Tsai; Fuh-Yuan Shih; Ann Yuan; Kuang-Chau Tsai; Fang-Yue Lin; Yuan-Teh Lee; Wen-Jone Chen
Journal:  Intensive Care Med       Date:  2006-11-15       Impact factor: 17.440

Review 7.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

8.  On the Efficacy of Cardio-Pulmonary Resuscitation and Epinephrine Following Cyanide- and H2S Intoxication-Induced Cardiac Asystole.

Authors:  Annick Judenherc-HaouzI; Takashi Sonobe; Vikhyat S Bebarta; Philippe Haouzi
Journal:  Cardiovasc Toxicol       Date:  2018-10       Impact factor: 3.231

9.  Current pharmacological advances in the treatment of cardiac arrest.

Authors:  Andry Papastylianou; S Mentzelopoulos
Journal:  Emerg Med Int       Date:  2011-11-20       Impact factor: 1.112

10.  The physiologic response to rescue therapy with vasopressin versus epinephrine during experimental pediatric cardiac arrest.

Authors:  Julia C Slovis; Ryan W Morgan; William P Landis; Anna L Roberts; Alexandra M Marquez; Constantine D Mavroudis; Yuxi Lin; Tiffany Ko; Vinay M Nadkarni; Robert A Berg; Robert M Sutton; Todd J Kilbaugh
Journal:  Resusc Plus       Date:  2020-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.